Skip to main content
logo
NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea flag South Korea · Delayed Price · Currency is KRW
25,450
+1,350 (5.60%)
Aug 11, 2026, 3:30 PM KST

NeoPharm CO., LTD. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
27,82323,06523,21317,02717,713
Depreciation & Amortization
3,1563,1501,6731,6161,500
Loss (Gain) From Sale of Assets
-59.117.173.76.053.23
Asset Writedown & Restructuring Costs
0.583.313.476.2311.07
Loss (Gain) From Sale of Investments
31.81-251.152.76--48.48
Provision & Write-off of Bad Debts
-89.1320.6895.42-0.1155.48
Other Operating Activities
-123.26-336.03834.24896.161,416
Change in Accounts Receivable
352.82-2,329-2,109855.53972.12
Change in Inventory
-3,479-3,443-1,840-1,108-94.7
Change in Accounts Payable
2,628-1,4052,732-643.79152.91
Change in Other Net Operating Assets
-1,831-161.29-1,355-494.970.34
Operating Cash Flow
28,41018,63123,26318,16121,681
Operating Cash Flow Growth
52.49%-19.91%28.09%-16.24%26.98%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,185-2,799-19,852-454-320.11
Sale of Property, Plant & Equipment
10.2-0.910.150.85
Sale (Purchase) of Intangibles
-40.82-277.99-975.96-352.43-158
Investment in Securities
-7,194-3,1364,487-8,000-16,002
Other Investing Activities
-1,002-18.974.028.57-203.9
Investing Cash Flow
-9,605-6,225-16,353-8,800-16,689

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
-----4,000
Long-Term Debt Repaid
-749.87-598.23-534.03-494.56-373.42
Total Debt Repaid
-749.87-598.23-534.03-494.56-4,373
Net Debt Issued (Repaid)
-749.87-598.23-534.03-494.56-4,373
Dividends Paid
-9,385-5,865-5,474-5,474-5,083
Other Financing Activities
-41.49-31.4791.79218.63-62.13
Financing Cash Flow
-10,176-6,495-5,917-5,750-9,519

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-38.48442.714.78223.43387.01
Miscellaneous Cash Flow Adjustments
-000--
Net Cash Flow
8,5906,353998.063,834-4,140

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
27,22515,8323,41117,70721,361
Free Cash Flow Growth
71.97%364.17%-80.74%-17.11%27.24%
Free Cash Flow Margin
20.60%13.30%3.51%20.82%24.29%
Free Cash Flow Per Share
1740.591012.16218.061132.041365.69
Levered Free Cash Flow
17,0169,760-4,49413,09417,851
Unlevered Free Cash Flow
17,0419,786-4,48013,10017,875

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
29.8937.8320.18.8439.51
Cash Income Tax Paid
6,4067,1256,3635,7165,069
Change in Working Capital
-2,330-7,338-2,573-1,3911,031